News
Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG (NOVN – Research Report) on April 24 and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback